Pfizer’s respiratory syncytial virus vaccine was more than 90% effective among older adults during the first season it was available, including among those with underlying conditions or severe disease ...

As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial ...

The respiratory syncytial virus vaccine is effective in reducing emergency visits, hospitalizations, and severe illness in ...

Revaccination with mRNA-1345 against RSV at 12 months was noninferior to primary vaccination among adults aged 50 years and older.

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...

Objectives The common cold is the main cause of medical time loss in elite sport. Rapid diagnosis has been a challenge that may be amenable to molecular point-of-care testing (POCT). Methods We ...

The federal government shutdown has brought respiratory virus surveillance to a halt at the national level, leaving local governments, health systems and the general public with critical blind spots ...

This story was originally published in 2022; it has since been updated. It started with a tickle in your throat. Then, it evolved into congestion, and maybe a little cough. Perhaps you lost your voice ...

An Ottawa mother learned RSV can have severe impacts on children, after her son ended up intubated at the hospital years ago. She's sharing her story as the weather gets colder, to prevent it from ...

Posters will be available to view on the conference platform during the conference and on the Company’s website here after presentations. Further information about IDWeek™ 2025 can be found here.

HUNTINGTON — The Cabell-Huntington Health Department received updated respiratory virus vaccine guidance from the West Virginia Department of Health on Wednesday, and the CEO said little has changed ...